An investor inquired about the current operation status of Guanghua Biochemical, a company in which Xiaosong Corporation acquired a 30% stake through disclosure in Announcement 2022-144. The investor also asked about the annual production volume of nicotine for e-cigarettes by Guanghua Biochemical.
On July 31st, Xiaosong Inc. announced that the operating conditions of Shanxi Ganghua, a company it has invested in, are normal, and the sales of nicotine for e-cigarettes are doing well.
Previously, Xiaosong Co. released its performance forecast for the first half of 2023, revealing a net profit attributable to the company's shareholders ranging from 28 million to 33 million yuan. In the same period last year, the net profit was 3.8986 million yuan, representing a year-on-year increase of 618.21% to 746.46%.
One of the reasons mentioned for the growth in performance is the increase in sales of e-cigarettes.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
